Bone marrow-CNS connections: Implications in the pathogenesis of diabetic retinopathy

Progress in Retinal and Eye Research

Volumn 31, Issue 5, 2012, Pages 481-494

  Yellowlees Douglas, Jane ^a   Bhatwadekar, Ashay D ^a   Li Calzi, Sergio ^a   Shaw, Lynn C ^a   Carnegie, Debra ^a   Caballero, Sergio ^a   Li, Quihong ^a   Stitt, Alan W ^b   Raizada, Mohan K ^a   Grant, Maria B ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Bone marrow; Central nervous system; Diabetic retinopathy; Inflammation; Neuroinflammation; Therapeutic approaches to diabetic retinopathy

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSE REDUCTASE INHIBITOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINOCYCLINE; ORAL ANTIDIABETIC AGENT; SALICYLIC ACID;

ANTIINFLAMMATORY ACTIVITY; APPETITE DISORDER; BLEEDING; BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; BONE MARROW; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG MEGADOSE; ENDOTHELIAL PROGENITOR CELL; GASTROINTESTINAL IRRITATION; GLYCEMIC CONTROL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTENSION; HYPOTHALAMUS; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MICROANGIOPATHY; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SATIETY; SIDE EFFECT; STROKE; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; VISUAL ACUITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; BLOOD-RETINAL BARRIER; BONE MARROW; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; HUMANS; SYMPATHETIC NERVOUS SYSTEM; VISUAL ACUITY; WEIGHT LOSS;

EID: 84863832833     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.04.005     Document Type: Review

References (146)

1. Afzal A., Shaw L.C., Ljubimov A.V., Boulton M.E., Segal M.S., Grant M.B. Retinal and choroidal microangiopathies: therapeutic opportunities. Microvasc. Res. 2007, 74:131-144.
2. Amin A.R., Attur M.G., Thakker G.D., Patel P.D., Vyas P.R., Patel R.N., Patel I.R., Abramson S.B. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:14014-14019.
3. Arauz-Pacheco C., Ramirez L.C., Pruneda L., Sanborn G.E., Rosenstock J., Raskin P. The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy. J. Diabetes Complications 1992, 6:131-137.
4. Arevalo J.F., Fromow-Guerra J., Sanchez J.G., Maia M., Berrocal M.H., Wu L., Saravia M.J., Costa R.A. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Retina 2008, 28:1387-1394.
5. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 2004, 61:661-666.
6. Arvanitakis Z., Wilson R.S., Schneider J.A., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology 2004, 63:996-1001.
7. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
8. American Diabetes Association Implications of the United Kingdom prospective diabetes study. Diabetes Care 1998, 21:2180-2184.
9. Awad O., Dedkov E.I., Jiao C., Bloomer S., Tomanek R.J., Schatteman G.C. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler. Thromb. Vasc. Biol. 2006, 26:758-764.
10. Bahlmann F.H., De Groot K., Spandau J.M., Landry A.L., Hertel B., Duckert T., Boehm S.M., Menne J., Haller H., Fliser D. Erythropoietin regulates endothelial progenitor cells. Blood 2004, 103:921-926.
11. Bailey A.J. Molecular mechanisms of ageing in connective tissues. Mech. Ageing Dev. 2001, 122:735-755.
12. Beishuizen A., Thijs L.G. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J. Endotoxin Res. 2003, 9:3-24.
13. Blake G.J., Ridker P.M. Tumour necrosis factor-alpha, inflammatory biomarkers, and atherogenesis. Eur. Heart J. 2002, 23:345-347.
14. Boyd-White J., Williams J.C. Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes. Diabetes 1996, 45:348-353.
15. Brugger W., Heimfeld S., Berenson R.J., Mertelsmann R., Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 1995, 333:283-287.
16. Busik J.V., Tikhonenko M., Bhatwadekar A., Opreanu M., Yakubova N., Caballero S., Player D., Nakagawa T., Afzal A., Kielczewski J., Sochacki A., Hasty S., Li Calzi S., Kim S., Duclas S.K., Segal M.S., Guberski D.L., Esselman W.J., Boulton M.E., Grant M.B. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J. Exp. Med. 2009, 206:2897-2906.
17. Butler J.M., Guthrie S.M., Koc M., Afzal A., Caballero S., Brooks H.L., Mames R.N., Segal M.S., Grant M.B., Scott E.W. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 2005, 115:86-93.
18. Caldwell R.B., Bartoli M., Behzadian M.A., El-Remessy A.E., Al-Shabrawey M., Platt D.H., Liou G.I., Caldwell R.W. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr. Drug Targets 2005, 6:511-524.
19. Caballero S., Sengupta N., Afzal A., Chang K.H., Li Calzi S., Guberski D.L., Kern T.S., Grant M.B. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007, 56:960-967.
20. Calegari, V.C., Torsoni, A.S., Vanzela, E.C., Araujo, E.P., Morari, J., Zoppi, C.C., Sbragia, L., Boschero, A.C., Velloso, L.A. Inflammation of the hypothalamus leads to defective pancreatic islet function. J. Biol. Chem. 286, 12870-12880.
21. Card, J.P., Kobiler, O., Ludmir, E.B., Desai, V., Sved, A.F., Enquist, L.W. A dual infection pseudorabies virus conditional reporter approach to identify projections to collateralized neurons in complex neural circuits. PLoS One 6, e21141.
22. Chang K.M., Lehrhaupt N., Lin L.M., Feng J., Wu-Wang C.Y., Wang S.L. Epidermal growth factor in gingival crevicular fluid and its binding capacity in inflamed and non-inflamed human gingiva. Arch. Oral Biol. 1996, 41:719-724.
23. Choi S.J., Kim F., Schwartz M.W., Wisse B.E. Cultured hypothalamic neurons are resistant to inflammation and insulin resistance induced by saturated fatty acids. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E1122-E1130.
24. Congdon N., O'Colmain B., Klaver C.C., Klein R., Munoz B., Friedman D.S., Kempen J., Taylor H.R., Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122:477-485.
25. Davis T.M., Stratton I.M., Fox C.J., Holman R.R., Turner R.C. U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Diabetes Care 1997, 20:1435-1441.
26. DCCT The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 1993, 329:977-986.
27. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., Boschero A.C., Saad M.J., Velloso L.A. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146:4192-4199.
28. Diabetes Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N. Engl. J. Med. 2000, 342:381-389.
29. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., Zeiher A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 2001, 108:391-397.
30. Dray A. Neuropathic pain: emerging treatments. Br. J. Anaesth. 2008, 101:48-58.
31. Dubey A.K. Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice. Indian J. Ophthalmol. 2006, 54:290. (author reply 290-291).
32. Ebstein W. Zur therapie des diabetes mellitus, insbesondere uber die anewendeng des salicylsuren natron bei demselben. Klin. Wochschr. 1876, 13:337-340.
33. Engerman R.L., Kern T.S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987, 36:808-812.
34. Engerman R.L., Kern T.S. Retinopathy in animal models of diabetes. Diabetes Metab. Rev. 1995, 11:109-120.
35. Enriori P.J., Evans A.E., Sinnayah P., Jobst E.E., Tonelli-Lemos L., Billes S.K., Glavas M.M., Grayson B.E., Perello M., Nillni E.A., Grove K.L., Cowley M.A. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 2007, 5:181-194.
36. Feinstein R., Kanety H., Papa M.Z., Lunenfeld B., Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 1993, 268:26055-26058.
37. Felinski E.A., Antonetti D.A. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy. Curr. Eye Res. 2005, 30:949-957.
38. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delia D., Sutherland D.R., Baker M.A., Greaves M.F. Expression of the CD34 gene in vascular endothelial cells. Blood 1990, 75:2417-2426.
39. Flamme I., Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 1992, 116:435-439.
40. Fletcher B.R., Calhoun M.E., Rapp P.R., Shapiro M.L. Fornix lesions decouple the induction of hippocampal arc transcription from behavior but not plasticity. J. Neurosci. 2006, 26:1507-1515.
41. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., Baynes J.W. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 1994, 43:676-683.
42. Gardiner T.A., Anderson H.R., Stitt A.W. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J. Pathol. 2003, 201:328-333.
43. Gebicke-Haerter P.J., Spleiss O., Ren L.Q., Li H., Dichmann S., Norgauer J., Boddeke H.W. Microglial chemokines and chemokine receptors. Prog. Brain Res. 2001, 132:525-532.
44. Goldfine A.B., Silver R., Aldhahi W., Cai D., Tatro E., Lee J., Shoelson S.E. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin. Transl. Sci. 2008, 1:36-43.
45. Grant M.B., May W.S., Caballero S., Brown G.A., Guthrie S.M., Mames R.N., Byrne B.J., Vaught T., Spoerri P.E., Peck A.B., Scott E.W. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 2002, 8:607-612.
46. Grant M.B., Schmetz I., Russell B., Harwood H.J., Silverstein J., Merimee T.J. Changes in insulin-like growth factors I and II and their binding protein after a single intramuscular injection of growth hormone. J. Clin. Endocrinol. Metabol. 1986, 63:981-984.
47. Graves D.T., Naguib G., Lu H., Leone C., Hsue H., Krall E. Inflammation is more persistent in type 1 diabetic mice. J. Dent. Res. 2005, 84:324-328.
48. Group S.R. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group. Arch. Ophthalmol. 1990, 108:1234-1244.
49. Group W.T.f.t.D.C.a.C.T.E.o.D.I.a.C.R Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003, 290:2159-2167.
50. Homsi S., Piaggio T., Croci N., Noble F., Plotkine M., Marchand-Leroux C., Jafarian-Tehrani M. Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study. J. Neurotrauma 2010, 27:911-921.
51. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
52. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95:2409-2415.
53. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
54. Hu F., Lu R., Huang B., Liang M. Free radical scavenging activity of extracts prepared from fresh leaves of selected Chinese medicinal plants. Fitoterapia 2004, 75:14-23.
55. Hundal R.S., Petersen K.F., Mayerson A.B., Randhawa P.S., Inzucchi S., Shoelson S.E., Shulman G.I. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 2002, 109:1321-1326.
56. National Eye Institute, 2004. Statement on the prevalence of diabetic retinopathy and age-related macular degeneration among Hispanic/Latino Americans (press release).
57. Joussen A.M., Murata T., Tsujikawa A., Kirchhof B., Bursell S.E., Adamis A.P. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 2001, 158:147-152.
58. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T.S., Adamis A.P. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004, 18:1450-1452.
59. Kanety H., Feinstein R., Papa M.Z., Hemi R., Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J. Biol. Chem. 1995, 270:23780-23784.
60. Kang H.W., Kim D., Kim H.J., Kim C.H., Kim Y.S., Park M.J., Kim J.S., Cho S.H., Sung M.W., Jung H.C., Lee H.S., Song I.S. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am. J. Gastroenterol. 2009, 105:178-187.
61. Katayama Y., Battista M., Kao W.M., Hidalgo A., Peired A.J., Thomas S.A., Frenette P.S. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124:407-421.
62. Kempen J.H., O'Colmain B.J., Leske M.C., Haffner S.M., Klein R., Moss S.E., Taylor H.R., Hamman R.F. The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthalmol. 2004, 122:552-563.
63. Kern T.S. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007, 2007:95103.
64. Kern T.S., Engerman R.L. Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp. Eye Res. 1995, 60:545-549.
65. Kern T.S., Engerman R.L. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia. Arch. Ophthalmol. 1996, 114:306-310.
66. Kern T.S., Engerman R.L. A mouse model of diabetic retinopathy. Arch. Ophthalmol. 1996, 114:986-990.
67. Kern T.S., Engerman R.L. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 2001, 50:1636-1642.
68. Kojima K., Matsubara H., Harada T., Mizuno K., Suzuki M., Hotta N., Kakuta H., Sakamoto N. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats. Jpn. J. Ophthalmol. 1985, 29:99-109.
69. Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994, 265:956-959.
70. Kowluru R.A., Chan P.S. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res. 2007, 2007:43603.
71. Kowluru R.A., Zhong Q., Kanwar M. Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes. Exp. Eye Res. 2010, 90:617-623.
72. Kramerov A.A., Saghizadeh M., Caballero S., Shaw L.C., Li Calzi S., Bretner M., Montenarh M., Pinna L.A., Grant M.B., Ljubimov A.V. Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Mol. Cell Biochem. 2008, 316:177-186.
73. Kreuter M., Langer C., Kerkhoff C., Reddanna P., Kania A.L., Maddika S., Chlichlia K., Bui T.N., Los M. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development. Arch. Immunol. Ther. Exp. (Warsz) 2004, 52:141-155.
74. Lai A.Y., Todd K.G. Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines. Glia 2006, 53:809-816.
75. Lalla E., Kaplan S., Yang J., Roth G.A., Papapanou P.N., Greenberg S. Effects of periodontal therapy on serum C-reactive protein, sE-selectin, and tumor necrosis factor-alpha secretion by peripheral blood-derived macrophages in diabetes. A pilot study. J. Periodontal Res. 2007, 42:274-282.
76. Li Calzi S., Purich D.L., Chang K.H., Afzal A., Nakagawa T., Busik J.V., Agarwal A., Segal M.S., Grant M.B. Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes. Diabetes 2008, 57:2488-2494.
77. Liu R., Bal H.S., Desta T., Krothapalli N., Alyassi M., Luan Q., Graves D.T. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J. Dent. Res. 2006, 85:510-514.
78. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., Walsh K., Isner J.M., Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 2001, 108:399-405.
79. Loomans C.J., van Haperen R., Duijs J.M., Verseyden C., de Crom R., Leenen P.J., Drexhage H.A., de Boer H.C., de Koning E.J., Rabelink T.J., Staal F.J., van Zonneveld A.J. Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Mol. Med. 2009, 15:152-159.
80. Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 2001, 154:635-641.
81. Maestroni G.J., Conti A., Pedrinis E. Effect of adrenergic agents on hematopoiesis after syngeneic bone marrow transplantation in mice. Blood 1992, 80:1178-1182.
82. Masuo, K., Lambert, G.W., Esler, M.D., Rakugi, H., Ogihara, T., Schlaich, M.P. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens. Res. 33, 521-528.
83. McMahon J.M., Wells D.J. Electroporation for gene transfer to skeletal muscles: current status. BioDrugs 2004, 18:155-165.
84. Mendez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
85. Mirshahi A., Roohipoor R., Lashay A., Mohammadi S.F., Abdoallahi A., Faghihi H. Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Eur. J. Ophthalmol. 2008, 18:263-269.
86. Mizutani M., Kern T.S., Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest. 1996, 97:2883-2890.
87. Monnier V.M., Vishwanath V., Frank K.E., Elmets C.A., Dauchot P., Kohn R.R. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N. Engl. J. Med. 1986, 314:403-408.
88. Moradian S., Ahmadieh H., Malihi M., Soheilian M., Dehghan M.H., Azarmina M. Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246:1699-1705.
89. Morgado, C., Pereira-Terra, P., Cruz, C.D., Tavares, I. Minocycline completely reverses mechanical hyperalgesia in diabetic rats through microglia-induced changes in the expression of the potassium chloride co-transporter 2 (KCC2) at the spinal cord. Diabetes Obes. Metab. 13, 150-159.
90. Naguib G., Al-Mashat H., Desta T., Graves D.T. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J. Invest. Dermatol. 2004, 123:87-92.
91. Ochner, C.N., Kwok, Y., Conceicao, E., Pantazatos, S.P., Puma, L.M., Carnell, S., Teixeira, J., Hirsch, J., Geliebter, A. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann. Surg. 253, 502-507.
92. Otani A., Kinder K., Ewalt K., Otero F.J., Schimmel P., Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 2002, 8:1004-1010.
93. Ott E.A., Kivipelto J. Influence of chromium tripicolinate on growth and glucose metabolism in yearling horses. J. Anim. Sci. 1999, 77:3022-3030.
94. Ozcan L., Ergin A.S., Lu A., Chung J., Sarkar S., Nie D., Myers M.G., Ozcan U. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009, 9:35-51.
95. Paul R.G., Bailey A.J. The effect of advanced glycation end-product formation upon cell-matrix interactions. Int. J. Biochem. Cell Biol. 1999, 31:653-660.
96. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
97. Persidsky Y., Ramirez S.H., Haorah J., Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 2006, 1:223-236.
98. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
99. Pierce J.W., Read M.A., Ding H., Luscinskas F.W., Collins T. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 1996, 156:3961-3969.
100. Posey K.A., Clegg D.J., Printz R.L., Byun J., Morton G.J., Vivekanandan-Giri A., Pennathur S., Baskin D.G., Heinecke J.W., Woods S.C., Schwartz M.W., Niswender K.D. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1003-E1012.
101. Pournaras, D.J., Aasheim, E.T., Bueter, M., Ahmed, A.R., Welbourn, R., Olbers, T., Le Roux, C.W. Effect of bypassing proximal gut on gut hormones involved with glycemic control and weight loss. Surg. Obes. Relat. Dis.
102. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
103. Purkayastha, S., Zhang, H., Zhang, G., Ahmed, Z., Wang, Y., Cai, D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc. Natl. Acad. Sci. U.S.A. 108, 2939-2944.
104. Quirici N., Soligo D., Caneva L., Servida F., Bossolasco P., Deliliers G.L. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br. J. Haematol. 2001, 115:186-194.
105. Ramana K.V., Friedrich B., Srivastava S., Bhatnagar A., Srivastava S.K. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 2004, 53:2910-2920.
106. Rameshwar P., Gascon P. Release of interleukin-1 and interleukin-6 from human monocytes by antithymocyte globulin: requirement for de novo synthesis. Blood 1992, 80:2531-2538.
107. Reid J., Macdougall A.I., Andrews M.M. Aspirin and diabetes mellitus. Br. Med. J. 1957, 2:1071-1074.
108. Rothwell P.M., Gutnikov S.A., McKinney P.A., Schober E., Ionescu-Tirgoviste C., Neu A. Seasonality of birth in children with diabetes in Europe: multicentre cohort study. European Diabetes Study Group. BMJ 1999, 319:887-888.
109. Sakagami Y., Girasole G., Yu X.P., Boswell H.S., Manolagas S.C. Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines. J. Bone Miner. Res. 1993, 8:811-816.
110. Sanchez M., Rene O.B.A., Ona V., Li H., Mingwei M.D., Friedlander M. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001, 48:1399-1401.
111. Schatteman G.C., Hanlon H.D., Jiao C., Dodds S.G., Christy B.A. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 2000, 106:571-578.
112. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F., Hammond W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
113. Shoelson S.E., Goldfine A.B. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat. Med. 2009, 15:373-374.
114. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
115. Sima A.A., Zhang W., Muzik O., Kreipke C.W., Rafols J.A., Hoffman W.H. Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide. Rev. Diabet. Stud. 2009, 6:211-222.
116. Sivan-Loukianova E., Awad O.A., Stepanovic V., Bickenbach J., Schatteman G.C. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J. Vasc. Res. 2003, 40:368-377.
117. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
118. Sorrell J.M., Baber M.A., Caplan A.I. Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng. Part A 2009, 15:1751-1761.
119. Stitt A.W., Anderson H.R., Gardiner T.A., Archer D.B. Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br. J. Ophthalmol. 1994, 78:133-137.
120. Stitt A.W., Frizzell N., Thorpe S.R. Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy. Curr. Pharm. Des. 2004, 10:3349-3360.
121. Takahashi K., Mitsui K., Yamanaka S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 2003, 423:541-545.
122. Tang J., Mohr S., Du Y.D., Kern T.S. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr. Eye Res. 2003, 27:7-13.
123. Tapia-Gonzalez, S., Garcia-Segura, L.M., Tena-Sempere, M., Frago, L.M., Castellano, J.M., Fuente-Martin, E., Garcia-Caceres, C., Argente, J., Chowen, J.A. Activation of microglia in specific hypothalamic nuclei and the cerebellum of adult rats exposed to neonatal overnutrition. J. Neuroendocrinol. 23, 365-370.
124. Thaler, J.P., Yi, C.X., Schur, E.A., Guyenet, S.J., Hwang, B.H., Dietrich, M.O., Zhao, X., Sarruf, D.A., Izgur, V., Maravilla, K.R., Nguyen, H.T., Fischer, J.D., Matsen, M.E., Wisse, B.E., Morton, G.J., Horvath, T.L., Baskin, D.G., Tschop, M.H., Schwartz, M.W. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153-162.
125. Thill M., Strunnikova N.V., Berna M.J., Gordiyenko N., Schmid K., Cousins S.W., Thompson D.J., Csaky K.G. Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:2696-2708.
126. Tikka T.M., Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-d-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 2001, 166:7527-7533.
127. UKPDS Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:837-853.
128. van de Sande-Lee S., Pereira F.R., Cintra D.E., Fernandes P.T., Cardoso A.R., Garlipp C.R., Chaim E.A., Pareja J.C., Geloneze B., Li L.M., Cendes F., Velloso L.A. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects. Diabetes 2011, 60:1699-1704.
129. Varma R., Paz S.H., Azen S.P., Klein R., Globe D., Torres M., Shufelt C., Preston-Martin S. The Los Angeles Latino Eye Study: design, methods, and baseline data. Ophthalmology 2004, 111:1121-1131.
130. Velloso L.A., Araujo E.P., de Souza C.T. Diet-induced inflammation of the hypothalamus in obesity. Neuroimmunomodulation 2008, 15:189-193.
131. Vincent J.A., Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 2007, 56:224-230.
132. Wang F.H., Liang Y.B., Zhang F., Wang J.J., Wei W.B., Tao Q.S., Sun L.P., Friedman D.S., Wang N.L., Wong T.Y. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 2009, 116:461-467.
133. Weiss M.J., Orkin S.H. In vitro differentiation of murine embryonic stem cells. New approaches to old problems. J. Clin. Invest. 1996, 97:591-595.
134. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., Thorpe S.R., Baynes J.W. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995, 34:3702-3709.
135. WHO WHO Diabetes Fact Sheet N312. Diabetes 2011.
136. Williamson R.T. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. Br. Med. J. 1901, 1:760-762.
137. Yan S.F., Ramasamy R., Schmidt A.M. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J. Mol. Med. (Berl.) 2009, 87:235-247.
138. Ye J. Regulation of PPARgamma function by TNF-alpha. Biochem. Biophys. Res. Commun. 2008, 374:405-408.
139. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., Ingram D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
140. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13496-13500.
141. Yune T.Y., Lee J.Y., Jung G.Y., Kim S.J., Jiang M.H., Kim Y.C., Oh Y.J., Markelonis G.J., Oh T.H. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 2007, 27:7751-7761.
142. Zhang Z.Y., Zhang Z., Fauser U., Schluesener H.J. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline. J. Cell Mol. Med. 2009, 13:341-351.
143. Zheng L., Gong B., Hatala D.A., Kern T.S. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest. Ophthalmol. Vis. Sci. 2007, 48:361-367.
144. Zheng M.H., Chen J., Kirilak Y., Willers C., Xu J., Wood D. Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human implantation. J. Biomed. Mater. Res. B Appl. Biomater. 2005, 73:61-67.
145. Zhou J., Wang S., Xia X. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr. Eye Res. 2012, 37:416-420.
146. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wuk D.C., Gullans S., Ferrante R.J., Przedborskikq S., Kristal B.S., Friedlander M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.